MAPT and Alzheimer disease: Studies since the discovery of amyloid beta (Aβ) and tau protein have provided detailed information on molecular pathological events, but little is known about the causes of AD, as well as about the possible effective treatment of this pathology (Silva et al., 2019; Tiwari et al., 2019).